Searched for
SII CEO
Serum Institute of India to manufacture Oxford Ebola vaccine backed by $8.6 million CEPI fundingSerum Institute of India will produce clinical trial doses of a new Ebola vaccine from Oxford University. This initiative is backed by fres...- ET Awards: Cyrus Poonawalla reflects on SII’s mission of affordable vaccines and saving lives worldwideCyrus Poonawalla began Serum Institute of India in 1966 with a goal to make India self-reliant in healthcare. His vision was to provide aff...
- Serum Institute joins CEPI network for vaccines against unknown pathogens (Disease X)Serum Institute of India (SII) has announced its partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) network, based...
- Posing as Adar Poonawalla, scammers dupe SII of Rs 1 cr, 7 nabbedAs per the complaint, Satish Deshpande, one of the directors at the SII had received a message on WhatsApp from a person posing as SII CEO ...
- US envoy, Novovax CEO hail role played by India and SII during COVID-19 pandemicThe delegates noted the critical role played by US-India cooperation in addressing the COVID-19 pandemic and other global health challenges...
- Serum Institute on lookout for partners to develop Monkeypox vaccineSII's CEO Adar Poonawalla told ET he was talking with partners who have the potential to develop the vaccine. He, however, said there was n...
- Serum Institute may face delay in Covovax launchIndia’s drug regulator has asked for the immunogenicity data from Serum Institute as the vaccine is not yet appoved by the US FDA.
- Government asks vaccine makers to ramp up productionSII CEO Adar Poonawalla in a meeting held on Friday with an inter-ministerial group formed by the government, is also learnt to have discus...
- Serum Institute of India plans to launch Covovax by June: Adar PoonawallaSII CEO Adar Poonawalla said on Saturday that its partnership for a Covid-19 vaccine with Novavax has shown excellent efficacy results. "We...
- Covishield dispatch for vaccine drive a historic moment: SIISerum Institute of India CEO Adar Poonawalla said the real challenge lies in taking the vaccine to the "common man, to the vulnerable group...
- 2020's parting shot: India to roll out COVID-19 vaccine in January"India is a part of 'COVAX'. We will keep giving 50 per cent of everything we make to India and to COVAX at the same time. India has such a...
- Centre may purchase 300-400 million Covishield doses by July 2021: Adar PoonawallaSII has partnered with global pharma giant AstraZeneca and Oxford University for the vaccine candidate 'Covidshield'. "As of now we don't h...
- Serum Institute looking for a $1 billion shot to fight covid, talks on with Blackstone, KKR and othersThe company, privately owned by Cyrus Poonawalla and his son Adar Poonawalla, plans to float a special purpose vehicle (SPV) for its vaccin...
- Serum Institute inks deal to produce US-based biotech firm Novavax’s Covid vaccineThe Serum Institute of India (SII) will buy the vaccine components from Novavax and the two companies will equally split the revenue from t...
- Serum Institute founder Cyrus Poonawalla to keep some vaccine aside for ParsisThe newsletter, Parsi Junction, reported that Poonawalla acceded to the request of former Bombay Parsi Panchayat (BBP) chairman Dinshaw Rus...
- Serum Institute to start manufacturing Oxford University's COVID vaccine in 3 weeks; launch by October if trials succeed"Our team has been working closely with Dr Hill from Oxford University, and we are expecting to initiate production of the vaccine in 2-3 w...
- Serum Institute to be ready with coronavirus vaccine by 2022SII announced that a vaccine candidate for the novel coronavirus, which has killed more than 2,000 people in China since its outbreak in De...
- Cipla ties up with Serum Institute to sell vaccines in South AfricaCipla said it had agreed to an exclusive deal with Serum Institute to supply vaccines to South Africa, adding a new market to their partner...
- Cipla Ltd to market Serum Institute's paediatric vaccines in EuropeCipla has launched multiple respiratory products in Europe this year, and launch of some key inhalers is expected in 2015.
- ICSI inks MoU with UK-based securities instituteInstitute of Company Secretaries (ICSI) today entered into an agreement with UK-based Securities and Investment Institute (SII) to facilita...
Load More
